Psoriasis plaque test

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Microplaque Assay; PPT

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Method for testing the topical, antipsoriatic potency of various substances.

IndicationThis section has been translated automatically.

S.u. Psoriasis vulgaris.

ImplementationThis section has been translated automatically.

  • First, selection of chronic inpatient plaques (mainly in the extremities) without inflammatory marginal activity (lesions should remain untreated before testing).
  • If there was a pre-treatment, a 14-day washout phase should be observed with topical applications and a 1-3-month washout phase with systemic treatment (corresponding to the half-life).
  • Then separate assessment of the severity of the individual symptoms (redness, scaling, infiltration).
  • Evaluation according to the following scheme (0 = not present, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe).
  • Addition of each score according to individual symptoms.
  • Sum corresponds to the initial activity (100%).
  • Subsequently, daily application of the test substance (with positive and negative controls!), either open or occlusive (e.g. with Finn-Chambers).
  • Daily careful washing of the test areas and if occlusive, renewal of the Finn-Chambers.
  • Daily determination of the score for each symptom.
  • Repeating the procedure for a total of 5-15 days (depending on pharmacological properties).
  • The final score corresponds to the so-called residual activity (compared to the initial activity).

Note(s)This section has been translated automatically.

  • Modifications exist with regard to the number of test fields, size of the areas, form of application, frequency of application, total duration, combination with systemic therapy, etc.
  • Due to the heterogeneity of psoriatic skin lesions, the test areas should rotate from patient to patient. Topographic influences should be minimized.
  • The evaluation of the test areas should not be performed immediately after washing, but with a latency of one hour. Scaling, for example, is not correctly detected after washing.
  • Skin irritation caused by plasters should be excluded.

LiteratureThis section has been translated automatically.

  1. Wozel G (2006) Is the psoriasis plaque test still relevant in the age of biologics? dermatologist 57: 672-678

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer